-
RBC: Apple Now Worth Just $130, We're Lowering March And June Estimates
Thursday, January 7, 2016 - 2:33pm | 201Read More...In a new report, RBC Capital Markets analyst Amit Daryanani explains why RBC has dialed back its expectations for Apple Inc. (NASDAQ: AAPL) in 2016. “We are lowering estimates on AAPL for March and June quarters to reflect supply chain data points coupled with the reality that compares...
-
RBC Likes Microsoft, Says Stock Now Worth $65
Wednesday, January 6, 2016 - 12:47pm | 288Read More...Microsoft Corporation (NASDAQ: MSFT) stock is now worth $65, according to analysts at RBC Capital Markets whom believe that sales, earnings and gross profits will pivot to growth in F2H16 and increase in FY17. "MSFT is emerging from a number of headwinds (model transition, FX and Nokia)...
-
RBC Cuts Helmerich & Payne, U.S. Silica On Valuation; Sees Little Upside
Sunday, September 20, 2015 - 11:24am | 360Read More...Analysts at RBC Capital Markets downgraded Helmerich & Payne, Inc. (NYSE: HP) and U.S. Silica Holdings Inc (NYSE: SLCA) from Outperform to Sector Perform. Valuation seems to be one of the main drivers behind these demotions. Shares of both companies were falling substantially on Friday trading...
-
Notable Metals Analyst Tempers Outlook On Gold, Silver Amid Fed's Rate Hike Cycle
Monday, August 24, 2015 - 1:10pm | 364Read More...While the attention of most of the financial world is now focused on the plummeting stock market, RBC Capital Markets recently released a report with their updated forecast for the gold and silver market. Conventional wisdom says that safety plays such as precious metals outperform during periods...
-
Google Could Move 4% After Earnings...Spread Between A & C Shares Won't Increase, RBC Predicts
Thursday, July 16, 2015 - 1:23pm | 320Read More...Google Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) shares are up 2.2 percent on Thursday, hours before the company's earnings announcement, set for 4:00 p.m. EDT. Wall Street is mixed on the issue. BMO's Daniel Salmon expects rising guidance in the coming quarters, while Credit Suisse's...
-
RBC's Mahaney Says The Street's Estimates For Facebook Will Go Up And So Will The Stock
Friday, July 10, 2015 - 1:59pm | 370Read More...Facebook Inc (NASDAQ: FB) is scheduled to declare its second quarter earnings on July 29. RBC's Mark Mahaney was on CNBC to discuss why the company won't disappoint with its results for the quarter. Facebook Is In A Sweet Spot Now "With Facebook and Facebook is one of our...
-
RBC's Mark Mahaney Disagrees With $1,600 Netflix Price Target By 2020
Friday, July 10, 2015 - 1:34pm | 319Read More...Stifel analyst Scott Devitt recently published a note to investors in which he mentioned his bullish scenario for Netflix, Inc. (NASDAQ: NFLX). RBC's Mark Mahaney was on CNBC Friday to weigh in on this. Mahaney also shared his outlook for Twitter Inc (NYSE: TWTR). Twitter Needs To...
-
RBC Says Biogen Can Move 10% After BIIB-037 Data Is Revealed
Friday, July 10, 2015 - 12:04pm | 317Read More...Biogen Inc (NASDAQ: BIIB) is down 3 percent on Friday after commentary from Cowen. Analyst Eric Schmidt suggested investors not play the company's upcoming AAIC data reveal centered on Aducanumab, scheduled for July 22, due to a lack of conviction. It didn't take long for RBC's...
-
Here's How Analysts Are Reacting To Oracle's Earnings Report
Thursday, June 18, 2015 - 11:21am | 414Read More...Oracle Corporation (NYSE: ORCL) shares slumped 6 percent and analysts trimmed their views after the software company said a business model shift and a stronger dollar hurt fiscal fourth-quarter results. "It would be easy to throw in the towel after a head-scratching quarter like this one,...
-
BioMarin's Results Are In: What Do They Mean?
Thursday, June 18, 2015 - 10:31am | 441Read More...Encouraging early results from a trial of BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) dwarfism treatment sent the company's shares higher Thursday while analysts boosted their targets. Shares changed hands recently at $138.50, up 12 percent. BioMarin said a trial of its vosoritide drug in...
-
RBC Offers 'All You Need To Know' Heading Into Apple's WWDC
Thursday, June 4, 2015 - 8:32am | 311Read More...Analysts at RBC said that the Apple Inc. (NASDAQ: AAPL) Worldwide Developers' Conference will focus primarily on software, according to a new research note. Namely, that will be a preview of iOS 9.0, as well as potential changes to OS X, according to analyst Amit Daryanani. The WWDC starts...
-
Puma Biotech Sinks On Drug Data; Analyst Upbeat
Tuesday, June 2, 2015 - 3:16pm | 322Read More...Puma Biotechnology Inc (NYSE: PBYI) plunged more than 13 percent on Tuesday after disappointing drug trial results, even as an analyst called the data "clearly positive." The development-stage biopharmaceutical company traded recently at $146.83, off $23.14, on more than three times...
-
Quest Diagnostics: What The Heck Is Happening?
Friday, May 22, 2015 - 12:24pm | 208Read More...Quest Diagnostics Inc (NYSE: DGX) is up nearly 10 percent on Friday after unconfirmed market chatter suggested the company has hired Goldman Sachs to explore a sale. Shares were halted on volatility at 10:34 a.m. ET, and since resuming, shares hit the $86 mark before trading down near $81....
-
Ann Q1 Earnings Preview
Thursday, May 21, 2015 - 2:44pm | 577Read More...Ann Inc (NYSE: ANN) will report Q1 earnings Friday ahead of the market open. The company has guided that revenue would come in at $605 million while the Wall Street consensus expected EPS of $0.33 on revenue of $604.87 million. In a May 4 note, RBC analyst Brian Tunick thought Ann “...
-
Urban Outfitters...The Day After
Tuesday, May 19, 2015 - 10:57am | 889Read More...Shares of Urban Outfitters, Inc. (NASDAQ: URBN) fell Monday following disappointing Q1 results. Following Tuesday’s open, the stock traded at $34.76, down 14.64 percent. Wall Street analysts weighed in on the results. Below are highlights along with current ratings and price targets....
